BriaCell Therapeutics Corp Warrant
BCTXW
BCTXW was delisted on the 26th of February, 2026.
3 hedge funds and large institutions have $2.97K invested in BriaCell Therapeutics Corp Warrant in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
2.6% less ownership
Funds ownership: 5.59% → 2.99% (-2.6%)
50% less funds holding
Funds holding: 6 → 3 (-3)
77% less capital invested
Capital invested by funds: $12.7K → $2.97K (-$9.69K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.88K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$1.37K |
| 3 |
HF
HRT Financial
New York
|
-$1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$24 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RAM
1
Redmond Asset Management
Henrico,
Virginia
| $2.36K | – | – | – |
|
|
TSS
2
Two Sigma Securities
New York
| $575 | -$1.37K | -35,231 | -66% |
|
|
NFSG
3
Newbridge Financial Services Group
Boca Raton,
Florida
| $32 | – | – | – |
|
|
AC
4
Armistice Capital
New York
| – | -$1.88K | -25,000 | Closed |
|
|
HF
5
HRT Financial
New York
| – | -$1K | -21,248 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$24 | -314 | Closed |
|
BCTXW Hedge Fund Activity: Q3 2025 in Review
3 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q3 2025, worth a combined $2.97K — down 77% from $12.7K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BCTXW and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Armistice Capital, exiting entirely with an estimated $1.88K sold.
- 3 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q3 2025, down from 6 in Q2 2025.
- Funds reported $2.97K of BriaCell Therapeutics Corp Warrant stock for Q3 2025, down 77% quarter-over-quarter.
- 0 funds opened new BriaCell Therapeutics Corp Warrant positions in Q3 2025 and 3 closed out, a net change of -3 holders.
- The largest BriaCell Therapeutics Corp Warrant seller in Q3 2025 was Armistice Capital, an estimated $1.88K sold.
Based on aggregated 13F filings for Q3 2025.